Companies / Chile
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
US, Chilean Drugs Row Reaches Stalemate
August 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
There has been little progress on concerns voiced by the US Ambassador to Chile, Craig Kelly, over alleged violations of intellectual property rights by indigenous drug manufacturers. Despite signing a free trade agreement (FTA) with the US in 2004, the Office of the US Trade Representative (USTR) has recently added Chile to its 'watch' list of countries where equitable market access by US firms is threatened. This has prompted speculation that the US may, in the longer term, call for the terms of the FTA to be